Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury.  These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication.

Pharmaceutical

Invirsa

Invirsa's headquarters in Columbus, OH, United States

Robert Shalwitz

Rachael Wingo

Isaiah Shalwitz

Tim Willis

Eric Donnenfeld

Beth Friedland

Kenneth Beckman

The Scientific Advisors at Invirsa provide expert guidance on the development and application of INV-102, ensuring its efficacy in promoting DNA repair and enhancing the innate immune response. They contribute to strategic decisions, oversee research methodologies, and aid in navigating regulatory requirements to advance the compound's clinical progress.

Scientific Advisors

The Leadership Team at Invirsa is responsible for strategic planning, decision-making, and overall direction of the company. This team, comprising the CEO, CFO, and VPs of Business Development & Operations, focuses on advancing the development of INV-102, optimizing resource allocation, and establishing partnerships to enhance innovation and growth in the field of wound healing and immune response. They drive the company’s mission to improve patient outcomes through effective collaboration and leadership.

Invirsa

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Invirsa

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Related companies